文献速递细菌感染、耐药与抗菌药物新发突发、热带与寄生虫病

肺炎链球菌遗传变异对侵袭性肺炎链球菌病临床表现的贡献

The Contribution of Genetic Variation of Streptococcus pneumoniae to the Clinical Manifestation of Invasive Pneumococcal Disease.
PubMed 文献 · Clin Infect Dis · 2019-01-01

该研究纳入349例荷兰两家医院2000-2011年肺炎链球菌菌血症患者,通过全基因组关联研究识别与23种临床侵袭性肺炎链球菌病表型相关的肺炎链球菌谱系、基因和等位基因变异,并在全国队列(n=482)和肺炎链球菌疫苗接种后队列(n=121)中验证。研究发现slaA基因是全国性验证的脑膜炎独立预测因子(OR 10.5,P=0.001),序列簇9(血清型7F)OR 3.68(P=0.057),4个共位于前噬菌体上的基因是30天死亡率的独立预测因子(OR 3.4,P=0.003)。结论认为肺炎链球菌基因型变异知识改善了侵袭性肺炎链球菌病不良临床表现的临床风险评估。

要点

  • slaA基因是全国性验证的脑膜炎独立预测因子(OR 10.5,P=0.001)。
  • 序列簇9(血清型7F)与脑膜炎相关(OR 3.68,P=0.057)。
  • 4个共位于前噬菌体上的基因是30天死亡率的独立预测因子(OR 3.4,P=0.003)。

核心结论

  • 肺炎链球菌基因型变异知识改善了侵袭性肺炎链球菌病不良临床表现的临床风险评估。
  • 这为针对、预测或避免特定肺炎链球菌变异相关致病效应提供了新机会,并表明肺炎链球菌基因型信息对侵袭性肺炎链球菌病的诊断和治疗策略很重要。
  • 需要持续监测以评估肺炎链球菌变异信息在动态微生物和易感宿主人群中的临床价值。

研究设计与样本

  • 索引队列为2000-2011年荷兰2家医院收治的349例肺炎链球菌菌血症患者。
  • 采用全基因组关联研究识别与23种临床侵袭性肺炎链球菌病表型相关的肺炎链球菌谱系、基因和等位基因变异。
  • 识别的关联在全国性队列(n=482)和肺炎链球菌疫苗接种后队列(n=121)中验证。
  • 通过回归分析检验确认的肺炎链球菌基因型相对于已知临床预测因子对临床侵袭性肺炎链球菌病表型的贡献。

主要发现

  • slaA基因是全国性验证的脑膜炎独立预测因子(OR 10.5,P=0.001)。
  • 序列簇9(血清型7F)为脑膜炎独立预测因子(OR 3.68,P=0.057)。
  • 4个共位于前噬菌体上的肺炎链球菌基因是30天死亡率的确认独立预测因子(OR 3.4,P=0.003)。
  • 可在这些患者血液样本中检测到关注的肺炎链球菌变异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要持续监测以评估肺炎链球菌变异信息在动态微生物和易感宿主人群中的临床价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Different clinical manifestations of invasive pneumococcal disease (IPD) have thus far mainly been explained by patient characteristics. Here we studied the contribution of pneumococcal genetic variation to IPD phenotype. METHODS: The index cohort consisted of 349 patients admitted to 2 Dutch hospitals between 2000-2011 with pneumococcal bacteremia. We performed genome-wide association studies to identify pneumococcal lineages, genes, and allelic variants associated with 23 clinical IPD phenotypes. The identified associations were validated in a nationwide (n = 482) and a post-pneumococcal vaccination cohort (n = 121). The contribution of confirmed pneumococcal genotypes to the clinical IPD phenotype, relative to known clinical predictors, was tested by regression analysis. RESULTS: Among IPD patients, the presence of pneumococcal gene slaA was a nationwide confirmed independent predictor of meningitis (odds ratio [OR], 10.5; P = .001), as was sequence cluster 9 (serotype 7F: OR, 3.68; P = .057). A set of 4 pneumococcal genes co-located on a prophage was a confirmed independent predictor of 30-day mortality (OR, 3.4; P = .003). We could detect the pneumococcal variants of concern in these patients' blood samples. CONCLUSIONS: In this study, knowledge of pneumococcal genotypic variants improved the clinical risk assessment for detrimental manifestations of IPD. This provides us with novel opportunities to target, anticipate, or avert the pathogenic effects related to particular pneumococcal variants, and indicates that information on pneumococcal genotype is important for the diagnostic and treatment strategy in IPD. Ongoing surveillance is warranted to monitor the clinical value of information on pneumococcal variants in dynamic microbial and susceptible host populations.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Cremers AJH, Mobegi FM, van der Gaast-de Jongh C, et al. The Contribution of Genetic Variation of Streptococcus pneumoniae to the Clinical Manifestation of Invasive Pneumococcal Disease. Clin Infect Dis. 2019. PMID: 29788414. doi:10.1093/cid/ciy417

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。